Chitosan microparticles loaded with yeast-derived PCV2 virus-like particles elicit antigen-specific cellular immune response in mice after oral administration

Electrospun Chitosan Microspheres for Complete Encapsulation of Anionic Proteins: Controlling Particle Size and Encapsulation Efficiency

(2013) Ji Suk Choi et al.   AAPS PHARMSCITECH

Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan

(2013) Tao Jiang et al.   BIOMATERIALS

A meta-analysis comparing the effect of PCV2 vaccines on average daily weight gain and mortality rate in pigs from weaning to slaughter

(2011) Charlotte Sonne Kristensen et al.   PREVENTIVE VETERINARY MEDICINE

New insights in mucosal vaccine development

(2011) Vincent Pavot et al.   VACCINE

Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV2)

(2011) Nathan M. Beach et al.   VIRUS RESEARCH

Oral Administration of  -1,3/1,6-Glucan to Dogs Temporally Changes Total and Antigen-Specific IgA and IgM

(2009) E. Stuyven et al.   Clinical and Vaccine Immunology

Beta-glucans as immunostimulant in vertebrates and invertebrates

(2009) S. Soltanian et al.   CRITICAL REVIEWS IN MICROBIOLOGY

The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts

(2009) Sergio A. Bucarey et al.   VACCINE

Effect of β-glucans on an ETEC infection in piglets

(2008) E. Stuyven et al.   VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY